In the formulation of Sir William Blackstone, the legal colossus of 18th-century England and 19th-century America, a judge ...

In this interview, Dr. Freya Leech, a researcher at NanoFCM, discusses the current challenges and future prospects in ...

Industry 5.0 shifts focus from efficiency to empathy—bringing human creativity and intelligent machines together to build ...

PepsiCo, which also makes Doritos, Cap’n Crunch cereal, Funyuns and Mountain Dew, announced in April that it would accelerate ...

Over $150 billion in investment and 5x BESS growth anticipated by 2030 are driving battery manufacturers to pursue faster, ...

South SF lab uses AI to strip hallucinations from psychedelics while keeping therapeutic benefits. Silicon Valley ...

Chulalongkorn University has partnered with The Ocean Cleanup and the Department of Marine and Coastal Resources to use ...

Beijing-based biotech unicorn METiS TechBio has rolled out what it calls the world's first AI-powered nano-delivery platform, ...

Impurities and instability are challenges for all drugs, but a growing range of technological tools are helping drug developers and manufacturers minimize them.

"Artificial intelligence (AI) is merely a tool, so if it is not provided with data, its predictive ability is inferior to ...

Trump, rescheduling, and the future of cannabis: chaos, risk, and opportunity as operators navigate federal change, markets, ...

Patients with chronic spontaneous urticaria (CSU) who remain symptomatic despite H1 antihistamine treatment now have a new oral treatment option, with the U.S. FDA’s approval of Novartis AG’s Rhapsido ...